MedPath

Ratifying dosage and duration for levo-bupivacaine, a local anaesthetic infusion by the caudal-epidural route in infants 3-6 months.

Phase 1
Conditions
Pain relief in infants undergoing surgical repair of bladder exstrophy
MedDRA version: 18.0 Level: PT Classification code 10054799 Term: Perioperative analgesia System Organ Class: 10042613 - Surgical and medical procedures
MedDRA version: 18.0 Level: PT Classification code 10036276 Term: Postoperative analgesia System Organ Class: 10042613 - Surgical and medical procedures
Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
Registration Number
EUCTR2015-000393-34-GB
Lead Sponsor
Central Manchester University Hospitals NHS Foundation Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

All infants aged between 3–6 months postnatal age, undergoing Bladder Exstrophy repair will be considered. But only those infants whose parents consent to a caudal-epidural block, as well as to this study will be included.
This is a rare condition and we see 5-7 patients/year. Taking into account the exclusion criteria we expect to take 18 months - 2 years to include 10 patients in the study.
Are the trial subjects under 18? yes
Number of subjects for this age range: 10
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range 0
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range 0

Exclusion Criteria

1. Lack of consent.
2. Known hypersensitivity to amide local anaesthetics.
3. History of seizures or neurological disorders.
4. Presence of blood-clotting disorders or blood dyscrasias.
5. Local congenital abnormalities/infection that contraindicates regional anaesthetic technique.
6. Technically difficult to administer the caudal - epidural block.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath